We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+5.45%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$819M
AUM Growth
+$123M
Cap. Flow
+$101M
Cap. Flow %
12.29%
Top 10 Hldgs %
9.75%
Holding
710
New
168
Increased
162
Reduced
95
Closed
285

Top Buys

Rank Stock Value
1
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$9.74M
2
MCD icon
McDonald's
MCD
+$8.2M
3
PARA
Paramount Global Class B
PARA
+$8.03M
4
AGN
Allergan plc
AGN
+$7.37M
5
HSIC icon
Henry Schein
HSIC
+$6.53M

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$7.17M
2
LRCX icon
Lam Research
LRCX
+$6.99M
3
EA icon
Electronic Arts
EA
+$6.98M
4
MBLY
Mobileye N.V.
MBLY
+$6.79M
5
HLT icon
Hilton Worldwide
HLT
+$6.5M

Sector Composition

Rank Sector Weight
1 Healthcare 15.19%
2 Technology 15.05%
3 Consumer Discretionary 14.44%
4 Financials 11.43%
5 Consumer Staples 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UGI icon
326
UGI
UGI
$7.92B
$569K 0.07%
12,133
+11,200
+1,200% +$547K
EOG icon
327
EOG Resources
EOG
$74.4B
$566K 0.07%
+5,850
New +$528K
OLLI icon
328
Ollie's Bargain Outlet
OLLI
$4.17B
$561K 0.07%
12,100
-100
-0.8% -$4.41K
AXS icon
329
AXIS Capital
AXS
$8.79B
$556K 0.07%
9,700
+7,800
+411% +$481K
BIO icon
330
Bio-Rad Laboratories Class A
BIO
$8.86B
$556K 0.07%
2,500
+2,300
+1,150% +$518K
DK icon
331
Delek US
DK
$3.85B
$556K 0.07%
20,800
+10,600
+104% +$265K
AXTA icon
332
Axalta
AXTA
$7.58B
$544K 0.07%
18,827
+17,627
+1,469% +$533K
APH icon
333
Amphenol
APH
$177B
$542K 0.07%
+25,600
New +$503K
COST icon
334
Costco
COST
$429B
$542K 0.07%
3,300
-24,400
-88% -$3.83M
GIMO
335
DELISTED
Gigamon Inc.
GIMO
$529K 0.06%
+12,543
New +$512K
ZTO icon
336
ZTO Express
ZTO
$18.2B
$528K 0.06%
37,605
+35,639
+1,813% +$514K
MRK icon
337
Merck
MRK
$326B
$524K 0.06%
8,575
-50,094
-85% -$3.04M
EVH icon
338
Evolent Health
EVH
$421M
$512K 0.06%
+28,781
New +$593K
PNFP icon
339
Pinnacle Financial Partners Inc
PNFP
$15.9B
$509K 0.06%
+7,600
New +$479K
SEDG icon
340
SolarEdge
SEDG
$2.44B
$505K 0.06%
+17,700
New +$446K
JPM icon
341
JPMorgan Chase
JPM
$950B
$497K 0.06%
5,200
-6,200
-54% -$572K
HUN icon
342
Huntsman Corp
HUN
$2B
$496K 0.06%
+18,106
New +$483K
UNVR
343
DELISTED
Univar Solutions Inc.
UNVR
$495K 0.06%
+17,100
New +$491K
GD icon
344
General Dynamics
GD
$106B
$493K 0.06%
2,400
-1,200
-33% -$240K
DST
345
DELISTED
DST Systems Inc.
DST
$488K 0.06%
+8,900
New +$487K
CNX icon
346
CNX Resources
CNX
$4.84B
$481K 0.06%
34,080
-18,840
-36% -$242K
CDK
347
DELISTED
CDK Global, Inc.
CDK
$479K 0.06%
7,600
-6,000
-44% -$378K
PCG icon
348
PG&E
PCG
$39.2B
$477K 0.06%
7,000
-73,500
-91% -$5.04M
SRCL
349
DELISTED
Stericycle Inc
SRCL
$473K 0.06%
6,600
-7,500
-53% -$552K
FITB
350
Fifth Third Bancorp
FITB
$52.4B
$470K 0.06%
+16,807
New +$446K
12 13
14
15 16

Similar funds

PP
Pegasus Partners Mequon, Wisconsin $1.07B AUM 32.32% 1-Year Est. Return
ECM
Ensemble Capital Management San Francisco, California $1.18B AUM 41.81% 1-Year Est. Return
GCAC
Guardian Capital Advisors (Canada) Toronto, Ontario, Canada $1.02B AUM 25.29% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return
D
Diversified Wilmington, Delaware $911M AUM 31% 1-Year Est. Return
GFS
GYL Financial Synergies West Hartford, Connecticut $1.33B AUM 34.46% 1-Year Est. Return
FTIS
First Trust Investment Solutions Naples, Florida $888M AUM 34.3% 1-Year Est. Return
AIA
Alera Investment Advisors Deerfield, Illinois $851M AUM 29.76% 1-Year Est. Return

Seven Eight Capital's Q3 2017 Portfolio in Review

As of Q3 2017, Seven Eight Capital held 710 positions worth $819M, up 18% from $696M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Seven Eight Capital deployed $101M of net new capital in Q3 2017, opening 168 new positions and adding to 162 existing holdings. Its largest new stake was Intercept Pharmaceuticals, Inc.: 90,387 shares worth $5.25M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 10% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Constellation Brands, an estimated $6.37M trimmed.

  • Seven Eight Capital's largest Q3 2017 buy was Intercept Pharmaceuticals, Inc.: 90,387 shares worth $5.25M.
  • Seven Eight Capital added most to McDonald's in Q3 2017, an estimated $8.2M increase.
  • Seven Eight Capital's biggest Q3 2017 reduction was Constellation Brands, cutting an estimated $6.37M.
  • Seven Eight Capital fully exited Nike in Q3 2017, selling an estimated $7.17M.
  • Seven Eight Capital's ten largest holdings make up 9.8% of its $819M portfolio in Q3 2017.
  • Seven Eight Capital opened 168 new positions and closed 285 in Q3 2017.
  • Seven Eight Capital's portfolio value rose 18% quarter-over-quarter to $819M.

Based on Seven Eight Capital's 13F filing for Q3 2017, filed 16 Oct 2017.